Evidence map›Paper›PMID 33203465›Full record

ArticleVeterinary research2020

Serotyping and pathotyping of Glaesserella parasuis isolated 2012-2019 in Germany comparing different PCR-based methods.

Lukas Schuwerk, Doris Hoeltig, Karl-Heinz Waldmann, Katrin Strutzberg-Minder, Peter Valentin-Weigand, Judith Rohde

Open access · goldAbstract readComparative Study
In one paragraph

Article in Veterinary research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Biology · 2026
    Article
  3. Article
  4. Pathotyping and molecular serotyping of clinical isolates of Glaesserella parasuis in Taiwan.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Epidemiology and pathogenicity ofFrontiers in microbiology · 2025
    Article
  9. Article
  10. Virulence and Antimicrobial Resistance Characterization ofAntibiotics (Basel, Switzerland) · 2024
    Article
  11. Distribution ofThe Canadian veterinary journal = La revue veterinaire canadienne · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Molecular Characterization and Phylogenetic Analysis ofPathogens (Basel, Switzerland) · 2023
    Article
  16. Article
  17. Screening of linear B-cell epitopes and its proinflammatory activities ofFrontiers in cellular and infection microbiology · 2023
    Article
  18. Serotyping and Antimicrobial Susceptibility Profiling ofPathogens (Basel, Switzerland) · 2022
    Article
  19. Article
  20. TbpBPathogens (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lukas SchuwerkInstitute for Microbiology, Department of Infectious Diseases, University of Veterinary Medicine, Foundation, Hannover, Germany.
Doris HoeltigClinic for Swine and Small Ruminants and Forensic Medicine and Ambulatory Service, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany.
Karl-Heinz WaldmannClinic for Swine and Small Ruminants and Forensic Medicine and Ambulatory Service, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany.
Katrin Strutzberg-MinderInnovative Veterinary Diagnostics Laboratory (IVD GmbH), Seelze, Germany.
Peter Valentin-WeigandInstitute for Microbiology, Department of Infectious Diseases, University of Veterinary Medicine, Foundation, Hannover, Germany.
Judith RohdeInstitute for Microbiology, Department of Infectious Diseases, University of Veterinary Medicine, Foundation, Hannover, Germany. Judith.Rohde@tiho-hannover.de.ORCID http://orcid.org/0000-0002-4671-2164
University of Veterinary Medicine Hannover, Foundation · DECS Diagnostics · DE

Funding

Deutsche Forschungsgemeinschaft Open Access Publishing Programme
6 · The paper itself

Abstract

Glaesserella parasuis is an important pathogen in swine production. It acts as a primary pathogen in systemic Glässer´s disease and as a secondary pathogen in Porcine Respiratory Disease Complex. In this study, a collection of 308 isolates from carrier animals and individuals with respiratory or Glässer´s disease isolated 2012-2019 in Germany was analysed. Isolates were characterized for serovar implementing two different PCR methods. Additionally, two different PCR methods for pathotyping isolates were applied to the collection and results compared. Serovar 6 (p < 0.0001) and 9 (p = 0.0007) were correlated with carrier isolates and serovar 4 was associated with isolates from animals with respiratory disease (p = 0.015). In systemic isolates, serovar 13 was most frequently detected (18.9%). Various other serovars were isolated from all sites and the ratio of serovar 5 to serovar 12 was approximately 1:2. These two serovars together represented 14.3% of the isolates; only serovar 4 was isolated more frequently (24.7%). The pathotyping method based on the leader sequence (LS = ESPR of vta) was easy to perform and corresponded well to the clinical background information. Of the carrier isolates 72% were identified as non-virulent while 91% of the systemic isolates were classified as virulent (p < 0.0001). Results of the pathotyping PCR based on 10 different marker genes overall were in good agreement with clinical metadata as well as with results of the LS-PCR. However, the pathotyping PCR was more complicated to perform and analyze. In conclusion, a combination of the serotyping multiplex-PCR and the LS-PCR could improve identification of clinically relevant G. parasuis isolates, especially from respiratory samples.

Indexed as

AnimalsGermanyHaemophilus InfectionsHaemophilus parasuisPolymerase Chain ReactionSerogroupSerotypingSus scrofaSwineSwine DiseasesVirulenceGlaesserella parasuisleader sequencepathotypingserotypingserovarvirulence

Identifiers

PMID33203465
PMCPMC7673094
OpenAlexW3098080874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.